Mela Sciences Says FDA Delays Approval On Skin Cancer Screening Device

March 25, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

March 24 (Reuters) - Mela Sciences (MELA.O) said U.S. health regulators delayed pre-market approval of its skin cancer screening device and sought more details, sending its shares tumbling as much as 29 percent.

Twitter
LinkedIn
Facebook
Email
Print

Food and Drug Administration (FDA)